SCHEMBL7817091

SCHEMBL7817091

NNC(=O)CCCc1ccccn1

nearest known ligand 0.60

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.60
CYP1A2 P05177 1/20 0.60
CYP2C19 P33261 1/20 0.60
HRH1 P35367 2/20 0.51
HDAC1 Q13547 1/20 0.49
TDP1 Q9NUW8 2/20 0.49
ALDH1A1 P00352 1/20 0.49
GAA P10253 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
HTT P42858 2/20 0.48
MAPK1 P28482 1/20 0.48
LMNA P02545 1/20 0.45
HRH3 Q9Y5N1 1/20 0.45
HRH2 P25021 1/20 0.44
KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7814882 0.90 TDP1 (0.55) SMN1; SMN2CYP1A2CYP2C19HRH1TDP1
SCHEMBL16561480 0.84 SMN1; SMN2 (0.60) SMN1; SMN2CYP1A2CYP2C19HRH1HDAC1
SCHEMBL9774 0.83 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19HRH1TDP1
Hydrochloric Acid SCHEMBL3513717 0.81 SMN1; SMN2 (0.66) SMN1; SMN2CYP1A2CYP2C19HRH1TDP1
SCHEMBL6687222 0.80 SMN1; SMN2 (0.73) SMN1; SMN2CYP1A2CYP2C19HRH1HDAC1
SCHEMBL3673389 0.80 SMN1; SMN2 (0.73) SMN1; SMN2CYP1A2CYP2C19HRH1HDAC1
SCHEMBL6196923 0.80 SMN1; SMN2 (0.68) SMN1; SMN2CYP1A2CYP2C19HRH1TDP1
SCHEMBL966286 0.80 CA1 (0.56) SMN1; SMN2CYP1A2TDP1HPGDALOX15
SCHEMBL29672808 0.80 CA1 (0.56) SMN1; SMN2CYP1A2TDP1HPGDALOX15
SCHEMBL7379830 0.79 SMN1; SMN2 (0.55) SMN1; SMN2CYP1A2CYP2C19HRH1HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0694546-B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and use SEARLE & CO (US) 2001-06-06 EP disclosed
EP-0694545-B1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use SEARLE & CO (US) 2000-07-26 EP disclosed
US-5576315-A Substituted dibenzoxazepine compounds and methods for treating osteoporosis and ischemia G.D. SEARLE & CO. (US) 1996-11-19 US disclosed
EP-0694546-A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. SEARLE & CO. (US) 1996-01-31 EP disclosed
EP-0694545-A2 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. SEARLE & CO. (US) 1996-01-31 EP disclosed
US-5464830-A ANALGESICS G. D. SEARLE & CO. (US) 1995-11-07 US disclosed
US-5378840-A Substituted dibenzoxazepine compounds G. D. SEARLE & CO. (US) 1995-01-03 US disclosed
WO-1992019617-A2 SUBSTITUTED DIBENZOXAZEPINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE G.D. SEARLE & CO. (US) 1992-11-12 WO disclosed
EP-0512400-A1 Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use G.D. Searle & Co. (US) 1992-11-11 EP disclosed